<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="24261">Glucocorticoid</z:chebi> (GC) receptor and terminal deoxynucleotidyl transferase (TdT) activities were studied in <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells to investigate their diagnostic and therapeutic implications </plain></SENT>
<SENT sid="1" pm="."><plain>Among cell lines with T-cell character, higher GC-receptor and TdT activities were found in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e> (HPB-ALL and ALL-Ichikawa) than in cells from adult pleomorphic T-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo> (HPB-MLT) </plain></SENT>
<SENT sid="2" pm="."><plain>HPB-Null with pre-B cell-character exhibited moderate GC receptor but low TdT activity; Raji cells and CCRF-SB, derived from B-cell Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>, respectively, manifested low GC receptor and no TdT activity </plain></SENT>
<SENT sid="3" pm="."><plain>The highest GC receptor activity was demonstrated in null-cell ALL, followed, in order, by juvenile <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e>, adult pleomorphic T-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Other kinds of lymphoid and monocytic <z:hpo ids='HP_0001909'>leukemias</z:hpo> exhibited low GC receptor and no TdT activity </plain></SENT>
<SENT sid="5" pm="."><plain>Although low GC receptor and negative TdT were demonstrated in cells from seven out of nine patients under <z:mp ids='MP_0005481'>CML</z:mp> blastic crisis, the last patient had cells with positive TdT and GC receptor activity </plain></SENT>
</text></document>